These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 3581068)

  • 21. Effect of treatment with submaximal and excessive doses of caerulein on pancreatic growth in newborn rats.
    Papp M; Dobronyi I; Varga G
    Acta Physiol Hung; 1989; 73(2-3):311-3. PubMed ID: 2596320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carcinogen-induced lesions in the rat pancreas: effects of varying levels of essential fatty acid.
    Roebuck BD; Longnecker DS; Baumgartner KJ; Thron CD
    Cancer Res; 1985 Nov; 45(11 Pt 1):5252-6. PubMed ID: 3876880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosporine inhibition of azaserine-induced atypical acinar cell foci in rat pancreas.
    Shinozuka H; Roebuck BD; Longnecker DS
    Pancreas; 1990 Jul; 5(4):389-93. PubMed ID: 2381899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut peptide receptors in pancreata of azaserine-treated and normal control rats.
    Tang C; Biemond I; Appel MJ; Visser CJ; Woutersen RA; Lamers CB
    Carcinogenesis; 1995 Dec; 16(12):2951-6. PubMed ID: 8603469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ghrelin attenuates the development of acute pancreatitis in rat.
    Dembinski A; Warzecha Z; Ceranowicz P; Tomaszewska R; Stachura J; Konturek SJ; Konturek PC
    J Physiol Pharmacol; 2003 Dec; 54(4):561-73. PubMed ID: 14726611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathologic and biochemical effects of azaserine in inbred Wistar/Lewis rats and noninbred CD-1 mice.
    Roebuck BD; Lilja HS; Curphey TJ; Longnecker DS
    J Natl Cancer Inst; 1980 Aug; 65(2):383-9. PubMed ID: 6931255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Divergent effects of retinoids on pancreatic and liver carcinogenesis in azaserine-treated rats.
    Longnecker DS; Kuhlmann ET; Curphey TJ
    Cancer Res; 1983 Jul; 43(7):3219-25. PubMed ID: 6601985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of pancreatic carcinogenesis by retinoids in azaserine-treated rats.
    Longnecker DS; Curphey TJ; Kuhlmann ET; Roebuck BD
    Cancer Res; 1982 Jan; 42(1):19-24. PubMed ID: 7053848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastrin receptor expression during azaserine-induced rat pancreatic carcinogenesis.
    Tsuei BJ; Povoski SP; Zhou W; Bell RH
    J Surg Res; 1996 Jun; 63(1):105-9. PubMed ID: 8661181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caloric restriction and intervention in pancreatic carcinogenesis in the rat.
    Roebuck BD; Baumgartner KJ; MacMillan DL
    Cancer Res; 1993 Jan; 53(1):46-52. PubMed ID: 8416749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentiation of azaserine by cholestyramine in the rat.
    Morgan RG; Papadimitriou JM; Crass RA
    Int J Exp Pathol; 1990 Aug; 71(4):485-91. PubMed ID: 2400737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ranitidine inhibits the trophic effect of caerulein on the pancreas in rats (preliminary data).
    Hidvégi E; Varga G; Papp M; Folly G; Scarpignato C
    Acta Physiol Hung; 1984; 64(3-4):475-8. PubMed ID: 6085212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endotoxemia in the infant rats modulates HSP60 protein level in the pancreatic acinar cells.
    Bonior J; Jaworek J; Kot M; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2007 Aug; 58 Suppl 3():189-98. PubMed ID: 17901594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of cholecystokinin and bombesin on development of azaserine-induced pancreatic tumours in rats: modulation by the cholecystokinin receptor antagonist lorglumide.
    Meijers M; Appel MJ; van Garderen-Hoetmer A; Lamers CB; Rovati LC; Jansen JB; Woutersen RA
    Carcinogenesis; 1992 Sep; 13(9):1525-8. PubMed ID: 1394835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of orchiectomy and testosterone on the early stages of azaserine-induced pancreatic carcinogenesis in the rat.
    Lhoste EF; Roebuck BD; Stern JE; Longnecker DS
    Pancreas; 1987; 2(1):38-43. PubMed ID: 3494994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promotion by unsaturated fat of azaserine-induced pancreatic carcinogenesis in the rat.
    Roebuck BD; Yager JD; Longnecker DS; Wilpone SA
    Cancer Res; 1981 Oct; 41(10):3961-6. PubMed ID: 7285004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoradiographic localization of cholecystokinin (CCK) receptor expression during the development of azaserine-induced rat pancreatic carcinoma.
    Tsuei BJ; Povoski SP; Zhou W; Bell RH
    Pancreas; 1996 Nov; 13(4):401-6. PubMed ID: 8899801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dietary modulation of azaserine-induced pancreatic carcinogenesis in the rat.
    Roebuck BD; Yager JD; Longnecker DS
    Cancer Res; 1981 Mar; 41(3):888-93. PubMed ID: 7459874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of polyamines synthesis inhibition on pancreas regeneration and phospholipase D activity after acute caerulein induced pancreatitis in rats. Biochemical and ultrastructural study.
    Jurkowska G; Rydzewska G; Andrzejewska A
    J Physiol Pharmacol; 1997 Dec; 48(4):789-804. PubMed ID: 9444625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition by neurotensin of azaserine-induced carcinogenesis in rat pancreas.
    Tatsuta M; Iishi H; Baba M; Nakaizumi A
    Int J Cancer; 1991 Feb; 47(3):408-12. PubMed ID: 1993548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.